Galderma Group N Capital Reinvestment Ratio
Galderma Group N capital reinvestment ratio. Galderma Group N (GALD) has a Capital Reinvestment Ratio of 0.08x as of June 2025, meaning it reinvests 0% of its operating cash flow (CHF475.06 Million) in capital expenditures (CHF37.07 Million). See Galderma Group N (GALD) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Galderma Group N (2021–2024)
Capital reinvestment ratio of Galderma Group N from 2021 to 2024. This chart tracks Galderma Group N's Capital Reinvestment Ratio across 4 annual periods. See Galderma Group N (GALD) flexibility index to measure the company's free cash flow as a share of total liabilities.
Galderma Group N Capital Reinvestment Ratio by Year (2021–2024)
Galderma Group N capital reinvestment ratio by year from 2021 to 2024. For the full cash flow conversion analysis, see cash efficiency ratio of Galderma Group N.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.64x | CHF429.77 Million | CHF275.00 Million | ▼ -6.8% |
| 2023 | 0.69x | CHF148.64 Million | CHF102.02 Million | ▼ -52.1% |
| 2022 | 1.43x | CHF106.30 Million | CHF152.33 Million | ▲ +119.1% |
| 2021 | 0.65x | CHF178.92 Million | CHF117.03 Million | — |